Publicacions en col·laboració amb investigadors/es de Newcastle University (4)

2021

  1. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390

2020

  1. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report from the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

    Journal of Clinical Oncology, Vol. 38, Núm. 31, pp. 3685-3697

2011

  1. A multilocus technique for risk evaluation of patients with neuroblastoma

    Clinical Cancer Research, Vol. 17, Núm. 4, pp. 792-804

  2. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

    British Journal of Cancer, Vol. 105, Núm. 12, pp. 1940-1948